Sunbelt Securities Inc. Has $670,000 Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Sunbelt Securities Inc. raised its stake in HCA Healthcare, Inc. (NYSE:HCA) by 10.8% in the second quarter, Holdings Channel.com reports. The firm owned 2,085 shares of the company’s stock after acquiring an additional 203 shares during the period. Sunbelt Securities Inc.’s holdings in HCA Healthcare were worth $670,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. increased its position in shares of HCA Healthcare by 0.4% during the first quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock valued at $5,666,569,000 after purchasing an additional 60,304 shares during the period. Wellington Management Group LLP raised its stake in shares of HCA Healthcare by 1.7% in the 4th quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock valued at $2,757,181,000 after buying an additional 170,560 shares in the last quarter. Royal Bank of Canada increased its stake in HCA Healthcare by 35.7% in the fourth quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after acquiring an additional 1,183,890 shares during the period. Capital World Investors lifted its stake in HCA Healthcare by 57.5% during the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after purchasing an additional 1,019,750 shares during the period. Finally, Royal London Asset Management Ltd. grew its stake in shares of HCA Healthcare by 11.9% in the 4th quarter. Royal London Asset Management Ltd. now owns 1,474,238 shares of the company’s stock valued at $399,047,000 after purchasing an additional 156,757 shares during the period. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

HCA opened at $405.45 on Wednesday. The company has a fifty day moving average price of $381.85 and a two-hundred day moving average price of $344.10. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. The firm has a market capitalization of $106.19 billion, a PE ratio of 20.21, a P/E/G ratio of 1.52 and a beta of 1.67. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $409.42.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company’s revenue was up 10.3% compared to the same quarter last year. During the same quarter last year, the business earned $4.29 earnings per share. As a group, analysts anticipate that HCA Healthcare, Inc. will post 22.46 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Stockholders of record on Monday, September 16th were issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.65%. The ex-dividend date of this dividend was Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

Insider Buying and Selling

In other news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of the business’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the sale, the senior vice president now owns 9,454 shares in the company, valued at approximately $3,436,623.54. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The disclosure for this sale can be found here. In the last three months, insiders sold 17,202 shares of company stock valued at $6,407,273. 1.60% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on HCA. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. UBS Group lifted their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a report on Wednesday, August 14th. Leerink Partners raised their price objective on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Truist Financial increased their price target on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, August 19th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research note on Friday, June 28th. Five analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $359.89.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.